PARATHYROID HORMONE 1-34 NASAL SPRAY, PREPARATION METHOD AND APPLICATION THEREOF

A parathyroid hormone 1-34 pharmaceutical composition and a preparation method thereof, specifically relating to a parathyroid hormone 1-34 pharmaceutical composition including parathyroid hormone 1-34 as an active ingredient and a pharmaceutically acceptable vector, the vector at least comprising a buffer liquid, a penetration enhancer, a stabilizer and a preservative. The parathyroid hormone 1-34 pharmaceutical composition is a parathyroid hormone 1-34 nasal spray or nasal spray composition. A parathyroid hormone 1-34 nasal spray or nasal spray composition prepared by means of the present method has the advantages of preventing the first pass effect, leading to high bioavailability; rapid onset of action; and convenient administration, strengthening patient compliance and being absorbed into the nasal mucosa when used, which may effectively reduce the pain of polypeptide drug injection..

Medienart:

Patent

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Europäisches Patentamt - (2021) vom: 14. Mai Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Beteiligte Personen:

ZHENG AIPING [VerfasserIn]
GAO JING [VerfasserIn]
WANG DAN [VerfasserIn]
ZHANG HUI [VerfasserIn]
DU YIMENG [VerfasserIn]
SU YUHUAI [VerfasserIn]
LIU QIAN [VerfasserIn]
HUA YABING [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

615
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
Che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2021-05-14, Last update posted on www.tib.eu: 2022-07-02, Last updated: 2023-02-09

Patentnummer:

WO2021088585

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA011677317